Novo Nordisk
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.About NVO
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments.
CEOLars Fruergaard Jørgensen
CEOLars Fruergaard Jørgensen
Employees76,302
Employees76,302
HeadquartersBagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded1931
Founded1931
Employees76,302
Employees76,302
NVO Key Statistics
Market cap354.70B
Market cap354.70B
Price-Earnings ratio23.63
Price-Earnings ratio23.63
Dividend yield1.48%
Dividend yield1.48%
Average volume9.84M
Average volume9.84M
High today$82.13
High today$82.13
Low today$79.43
Low today$79.43
Open price$81.41
Open price$81.41
Volume7.49M
Volume7.49M
52 Week high$148.15
52 Week high$148.15
52 Week low$57.00
52 Week low$57.00
NVO News
Seeking Alpha 3d
Novo Nordisk taps Nvidia to accelerate drug discovery through AINvidia (NASDAQ:NVDA) announced a collaboration with Novo Nordisk (NVO) (OTCPK:NONOF) on Wednesday to speed up the Danish pharma giant's efforts in drug discover...
Sherwood News 5d
Obesity treatment startup Metsera rises on positive trial resultsObesity treatment startup Metsera rises on positive trial results New York-based obesity treatment startup Metsera is up by double digits after it reported enc...
Analyst ratings
60%
of 30 ratingsBuy
60%
Hold
30%
Sell
10%